Table 3.

Impact of Prognostic factors on Outcome

	N	NRM at Day 100		P-Value	Risk of Cardiac Complications	95% CI	P- Value
		HR	95% CI		HR
Age
≤43	28	Ref.			Ref.
>43	28	2.6	0.5–13.4	0.25	2.9	0.6–15.2	.2
HCT-CI
1–2	39	Ref
>2	17	0.9	0.2–4.5	0.9	0.3	0.04–2.8	0.3
Donor type
Matched related	23	0.2	0.02–1.4	0.1	0.5
Matched unrelated	23	Ref.			Ref.		0.8
Mismatched	10	0.4	0.05–3.8	0.5	can’t estimate
Pre-TP LVEF
≤35	10	Ref.			Ref.
36–40	21	1.6	0.2–15.1	0.7	1.6	0.2–16	0.7
>40	25	1.3	0.1–13	0.8	1.3	0.1–12.5	0.8
Smoking status
Smoker	20	0.7	0.1–3.4	0.6	3.9	0.7–20.2	0.1
Nonsmoker	36	Ref.
Prep regimen
Ablative	21	0.7	0.1–3.4	0.6	0.2	0.03–2.0	0.2
Reduced intensity	35	Ref.
Cyclophosphamide in prep regimen
Yes	17	0.9	0.2–4.7	0.9	1.6	0.3–6.9	0.6
No	39	Ref.
Diagnosis
Acute leukemia	32	Ref.			Ref.
Lymphoma	16	1.5	0.2–8.8	0.7	1.4	0.2–8.4	0.7
Others	8	3	0.5–17.9	0.2	3.5	0.5–18.3

NRM indicates nonrelapse mortality; HR, hazard ratio; CI, confidence interval; HCT-CI, hematopoietic stem cell transplantation comorbidity index; TP, transplant; Prep regimen, preparative regimen.